Evaluate the Association Between Infection and Thrombocytopenia

Thrombocytopenia Clinical Trial

Official title:

Evaluate the Association Between Blood Stream Infection (BSI) and Thrombocytopenia (Surgical Intensive Care Unit)SICU Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02263157
• Other study ID #: BSI-PLT
• Status: Completed
• Phase: N/A
• First received: October 5, 2014
• Last updated: October 8, 2014
• Start date: January 2013
• Est. completion date: June 2014

Study information

• Verified date: October 2014
• Source: Jinling Hospital, China
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Chinese Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

The study is designed to evaluate the association between nosocomial bloodstream infection and the occurrence of thrombocytopenia in surgical critical ill patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 390
• Est. completion date: June 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Sequential consenting adult patients of either sex were prospectively enrolled into the study.

Exclusion Criteria:

• Patients who passed away within 24 hours after hospitalization would be excluded.

Patients who developed into a bloodstream infection within 48 hours after hospital admission were also excluded.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Thrombocytopenia
• Thrombocytosis

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Jinling Hospital, China

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	mortality rate		28 days	No